Application Whitelisting and Control on Endpoints

Application whitelisting is a security control that restricts execution on an endpoint to a pre-approved set of software, scripts, libraries, and processes — blocking everything not explicitly permitted. This page covers the definition and regulatory scope of application whitelisting, the technical mechanisms through which it operates, the deployment scenarios where it is most commonly applied, and the decision boundaries practitioners use to select and configure controls. The control is relevant across federal, healthcare, and critical infrastructure environments where unauthorized code execution represents a primary threat vector.

Definition and scope

Application whitelisting — also referred to as application allowlisting in current NIST terminology — is the practice of maintaining an explicit list of authorized executables, scripts, installer packages, and libraries, with all unlisted code blocked from running by default. NIST SP 800-167, Guide to Application Whitelisting defines the control as an approach that "allows only specific programs to operate on a system" and distinguishes it categorically from blacklisting, which blocks known-bad code while permitting everything else.

The regulatory scope of application whitelisting spans multiple US compliance frameworks:

• NIST SP 800-53, Rev 5, Control CM-7(5) requires organizations to identify authorized software programs, employ a deny-by-default approach, and review and update the authorized software list at a defined frequency (NIST SP 800-53 Rev 5).
• CMMC 2.0 (32 CFR Part 170), at Level 2 and above, maps to NIST SP 800-171 Practice 3.4.8, which requires restricting or disabling the use of programs and functionality on information systems not required for operation (CMMC Model Overview, DoD).
• HIPAA Security Rule (45 CFR §164.312) does not mandate whitelisting by name but requires covered entities to implement technical safeguards — a gap that HHS guidance documents consistently address by referencing application control as a recommended compensating control.
• CISA, through its Continuous Diagnostics and Mitigation (CDM) Program, includes software asset management and application allowlisting as Phase 1 capabilities for federal civilian agencies (CISA CDM Program).

The scope of assets subject to application whitelisting extends beyond traditional workstations. NIST SP 800-167 covers general-purpose computing devices, servers, and mobile devices. Industrial control system guidance — including NIST SP 800-82, Rev 3 — extends the control to operational technology endpoints where patching is infrequent and the software baseline is stable.

How it works

Application whitelisting operates through an enforcement agent installed on the endpoint — typically a kernel-level driver or OS-integrated mechanism — that intercepts execution requests and compares them against an authorization policy before permitting or blocking the action. The enforcement sequence follows a discrete set of phases:

1. Inventory and baseline establishment — All currently executing software, scripts, and libraries are catalogued to establish the authorized baseline. NIST SP 800-167 recommends capturing file path, cryptographic hash, publisher certificate, and product name as identifying attributes.
2. Policy rule authoring — Rules are written using one or more identification methods: cryptographic hash (most precise, least flexible), publisher certificate or code signing (flexible, vendor-dependent), file path and name (least secure, most operationally common), or a combination.
3. Enforcement mode selection — Enforcement is staged: audit mode logs all execution events without blocking, allowing administrators to identify policy gaps before moving to block mode, which actively denies unauthorized execution.
4. Exception and change management — Software deployments, patches, and new tools require a formal approval workflow before being added to the authorized list. Without a structured change process, exception creep degrades policy integrity.
5. Continuous review — Authorized software lists must be reviewed on a defined schedule. CM-7(5) in NIST SP 800-53 specifies frequency as organization-defined, but CIS Benchmark guidance for Windows environments recommends review cycles aligned with patch windows — typically 30-day intervals.

The control operates in two architecturally distinct modes at the OS level: default-deny (nothing runs unless explicitly permitted) and default-allow with selective blocking (blacklisting). Default-deny is the model required by NIST SP 800-167 and is the only configuration that satisfies CM-7(5) at its full intent. Default-allow configurations do not constitute application whitelisting under NIST's definition, even if they use the same tooling.

Common scenarios

Application whitelisting is deployed with the highest density in environments with a defined, stable software baseline — where the set of authorized applications changes infrequently relative to the threat exposure:

Federal agency workstations represent the most extensively regulated deployment context. The CDM Program's software asset management capability requires federal agencies to maintain real-time visibility into installed software and block unauthorized execution across civilian agency endpoints. CISA's binding operational directives have repeatedly invoked application control requirements following incidents attributed to unauthorized script execution.

Industrial control system (ICS) and operational technology (OT) endpoints are a high-fit use case because their software baselines are intentionally static — a programmable logic controller's authorized software set may not change for months or years. NIST SP 800-82 Rev 3 identifies application whitelisting as a preferred compensating control where traditional endpoint detection and response tools cannot be installed due to hardware or OS constraints.

Healthcare endpoint environments subject to HIPAA deploy application whitelisting primarily on clinical workstations and medical device management servers where the authorized application set is dictated by clinical workflow and device certification requirements. See the Endpoint Security Providers section for providers operating in this vertical.

Contractor and defense industrial base (DIB) endpoints subject to CMMC 2.0 must satisfy Practice 3.4.8, making application control a required capability rather than an optional hardening measure for organizations seeking Level 2 certification.

Decision boundaries

Practitioners and procurement professionals evaluating application whitelisting controls navigate four primary decision axes:

Identification method: hash vs. certificate vs. path
Cryptographic hash-based rules provide the strongest assurance — a file must match exactly — but require policy updates for every patch cycle. Certificate-based rules trust all software signed by a named publisher, reducing maintenance overhead at the cost of trusting the publisher's entire signing chain. Path-based rules are operationally simplest but can be bypassed by placing unauthorized executables in trusted provider network locations. Most enterprise deployments combine certificate-based rules for vetted vendors with hash-based rules for internally developed or unsigned tools. The endpoint security provider network purpose and scope page describes how providers in this sector categorize their control implementations.

Scope: user-mode only vs. kernel-mode and driver control
Basic application whitelisting covers user-mode executables and scripts. Advanced configurations extend control to kernel-mode drivers — a capability required by NIST SP 800-167 for high-security environments where rootkit-class threats are in scope. Kernel-mode control requires OS-level integration (e.g., Windows Defender Application Control operating in KMCI mode) and introduces compatibility risk with legacy hardware drivers.

Enforcement posture: audit mode vs. block mode
Audit mode is operationally necessary during initial deployment to identify gaps in the authorized baseline before blocking is activated. Remaining in audit mode indefinitely — a common failure pattern — provides logging visibility but no execution prevention. NIST SP 800-167 explicitly frames audit mode as a transitional state, not a permanent operating posture.

Script and interpreted language control
Standard executable-level whitelisting does not inherently control PowerShell scripts, Python files, or macro-enabled documents unless the enforcement engine is configured to intercept interpreter invocations and evaluate the scripts themselves. This boundary — where executable control ends and script control begins — is a documented gap that threat actors exploit. CISA advisories on ransomware deployment chains have repeatedly identified malicious script execution through trusted interpreters as the initial execution vector on systems with incomplete application control implementations. For additional context on how application whitelisting fits within the broader endpoint control landscape, the how to use this endpoint security resource page describes the classification structure used across this reference.

References

• NIST SP 800-167, Guide to Application Whitelisting
• NIST SP 800-53 Rev 5, Security and Privacy Controls for Information Systems and Organizations
• NIST SP 800-82 Rev 3, Guide to OT Security
• NIST SP 800-171 Rev 2, Protecting CUI in Nonfederal Systems
• CMMC Model Overview — U.S. Department of Defense
• CISA Continuous Diagnostics and Mitigation (CDM) Program
• HHS HIPAA Security Rule, 45 CFR §164.312
• Microsoft Windows Defender Application Control Documentation